A rat pheochromocytoma (PC12) cell line was used to study the effects of several polymethoxylated flavonoids 
Introduction
Oxidative stress is a risk factor in the occurrence and progression of various diseases including Alzheimer's disease (AD), atherosclerosis and ischemia (Wadsworth, 2008) . Fortunately, since plants contain a wide variety of free radical scavenging molecules such as flavonoids, anthocyanins, carotenoids, dietary glutathione and vitamins, they have received growing attention as chemopreventive agents against oxidative damage (Fabiana et al., 2008) . Especially, natural flavonoids, which are promising antioxidant products, can easily penetrate the blood-brain barrier (Seung et al., 2012; GilgunSherki et al., 2001; Manthey et al., 2001) Besides inhibiting the key enzymes in mitochondrial respiration and protecting against coronary heart disease, these flavonoids also have anti-spasmolytic, anti-inflammatory, antioxidative, vascular, estrogenic, cytotoxic, antitumor, and antimicrobial activities (Wang et al., 2007; Benavente-Garcia et al., 2008) .
In our previous studies, the extraction process of ECRP was optimized by using response surface methodology with antioxidant activity as the indicator (Mo et al., 2012) . A series of in vitro antioxidant models suggested that the extract of ECRP possessed excellent antioxidant activity and scavenging activity against free radicals. In addition, D-galactose-induced aging mice model experiments showed that ECRP not only reduced the malondialdehyde (MDA) levels but also improved the activities of SOD and GSH-Px in blood, liver and brain. Furthermore, the components of ECRP in plasma were mainly identified as PMFs based on the principle of serum medicinal chemistry . Then the PMFs were isolated and purified by silica gel column chromatography and the structures were identified by nuclear magnetic resonance spectroscopy and UV absorption spectroscopy.
Taken together, ECRP exhibited significant antioxidant effects in vitro and in vivo, and PMFs were mainly absorbed in blood.
However, the intracellular antioxidant activities of these flavanones have not been tested. Therefore, it is necessary to investigate whether and how PMFs work in vivo by cellular antioxidant activity assay. Although the protective effects of citrus flavanones on hydrogen peroxide-induced cytotoxicity have been reported (Lu et al., 2010; Hwang et al., 2008) , the antioxidant effects of other PMFs of ECRP, except for nobiletin and tangeretin, have never been studied. Thus, this study aimed to first evaluate the protective effects of PMFs of ECRP on PC12 cells against H 2 O 2 -induced cytotoxicity. Moreover, pharmacokinetics should be studied to determine how much PMFs can be absorbed in blood to exert effects, and to unravel the mechanism of compatibility and action of ECRP, especially because oral bioavailability significantly limits the efficacy of the PMFs. It is of great importance to obtain the detailed pharmacokinetics and to find out the relationship between oral dosage and antioxidant effect of ECRP PMFs. Although Manthey et al. (2011) and Saigusa et al. (2011) have developed simultaneous determination methods to measure the contents of PMFs in sera of animals, they just focused on the pharmacokinetics of purified compounds. In contrast, the pharmacokinetics and bioavailability of PMFs in plant extract have never been reported hitherto. Thus, this study also evaluated the pharmacokinetics of nobiletin and tangeretin that have the highest contents of PMFs.
A Cellular Antioxidant Activity Assay Materials and Methods

M a t e r i a l s
N o b i l e t i n , t a n g e r e t i n , h e s p e r i d i n , 5-hydroxy-6,7,8,3',4'-5 methoxy flavones, 5,7,8,4'-4 methoxy flavones, 5,6,7,3',4'-5 methoxy flavones, 3,5,6,7,8,3',4'-7 methoxy flavones and ECRP were prepared by our group. 3-(4,5-Dimethyl The dark blue formazan crystals formed in intact cells were solubilized with dimethylsulfoxide (DMSO), and their optical density was measured at 570 nm using a microplate reader.
Measurement of MDA, total SOD, and GSH-Px
At the end of the treatment, cells were digested with trypsin and collected by centrifuge at 1000 × g for 3 min, and cell pellets were washed 3 times with PBS and then centrifuged again. The supernatant was discarded, and 400 µL of cold PBS (4℃) was added to suspend the cell pellets. Then the homogenate was prepared by ultrasonication at 4℃. MDA level and total activities of SOD and GSH-Px in the supernatant were measured spectrophotometrically according to the manufacturer's instructions, respectively.
Statistical analysis
All experiments were performed in triplicate. Data were presented as mean ± SD. The Duncan test and one-way ANOVA were used for multiple comparisons using SPSS 12.0 software (SPSS, Chicago, USA). P < 0.05 was used to indicate that the difference between groups was statistically significant.
Pharmacokinetics Study Materials and Methods
Materials and reagents Nobiletin (>97% purity) and tangeretin (>96% purity) were prepared in our group. Quercetin (99.3% purity), which was used as the internal standard, was purchased from the Chinese National Institute for the Control of 
Preparation of standard solutions Stock solutions of nobiletin
and tangeretin were prepared at 2 mg mL _ 1 and IS (quercetin) was prepared at 1 mg mL _ 1 in methanol after the correction for purity.
All the stock solutions were stored at 4℃, brought to room temperature and further diluted to make working solutions. To calculate the administration dose, the contents of nobiletin and tangeretin in ECRP were first quantitatively analyzed. The conditions for HPLC analysis were modified based on a previously published method . The contents of nobiletin and tangeretin in ECRP were determined to be 13.30 and 10.68 mg/g, respectively.
Nobiletin and tangeretin were orally administered to rats at the dosages of 260.6 and 213.6 mg kg _ 1 respectively for 20 mL kg 
Method validation
The specificity of the method was assessed by comparing the lowest concentration in the calibration curves with that of blank rat plasma that had undergone the same pretreatment and analysis.
Calibration curves were plotted by spiking blank plasma with
proper volumes of one of the working solutions mentioned above to produce the final standard curve points equivalent to 2500, 1000, 500, 250.0, 100.0, 50.0, 25.00, 10.00 and 5.000 ng mL _ 1 nobiletin and tangeretin, respectively. The subsequent assay procedures were the same as those described above. Calibration curves were generated by using the ratios of the analyte peak area to the IS peak area vs. concentration and were fitted to the equation y = bx + a by weighted least-squares linear regression, where x corresponds to the peak area ratio and y refers to the concentration added to plasma.
Quality control (QC) samples were prepared by spiking blank plasma with proper volumes of one of the working solutions mentioned above to produce the final concentrations equivalent to 5.000 ng mL _ 1 (low level), 250.0 ng mL _ 1 (moderate level) and 2500 ng mL _ 1 (high level) nobiletin and tangeretin, respectively.
The following procedures were the same as those described above.
The limit of detection (LOD) and the limit of quantification (LOQ)
were determined as the concentrations with signal-to-noise ratios of 3 and 10, respectively.
The precision was evaluated by assaying five replicates of QC samples at low, moderate and high concentrations (5.000, 250.0 and 2500 ng mL _ 1 ) on the same day for five consecutive days. The accuracy was determined by analyzing five sets of spiked plasma samples of nobiletin and tangeretin at each QC level on the same day. Precision was measured by intra-and inter-day relative standard deviations (RSDs) and accuracy was described as relative error (RE).
The extraction recoveries were determined at three QC levels by comparing the peak area obtained from plasma sample spiked before extraction with from plasma samples spiked those after extraction. This procedure was repeated (n = 5) at each QC level 
Results and Discussion 1 Cellular Antioxidant Activity Assay
Determination of injury concentration of H 2 O 2
The viability of PC12 cells after treatment with 100 µM H 2 O 2 for 4 h, which was measured by MTT reduction assay, decreased to 85% of controls (Fig. 1) . In other words, PC12 cells were only mildly damaged.
Thus, 100 µM H 2 O 2 was used to produce oxidative stress to PC12 cells in the cellular antioxidant activity assay. 
Determination of Optimum concentrations of PMFs and ECRP
As shown in Fig. 2 
PMFs and ECRP Protected PC12 Cells against H 2 O 2 -Induced
Cytotoxicity The effects of PMFs and ECRP on MDA level reduction, lipid peroxidation, activities of SOD and GSH-Px were evaluated as described above. H 2 O 2 alone increased the MDA level and decreased the activities of SOD and GSH-Px significantly compared with those of the control groups (P < 0.01) ( 
Pharmacokinetics Study Method validation
Representative chromatograms obtained from blank plasma, blank plasma spiked with the analytes and IS, and plasma sample after oral administration are shown in Fig. 3 . No endogenous interference appeared at around the retention times of the analytes and IS in drug-free specimens. The retention times of IS, nobiletin and tangeretin (Fig. 3, panel 3 Intra-day and inter-day precisions and accuracies of the method for nobiletin and tangeretin are presented in Table 2 . The intra-day and inter-day precision deviations were all within 15% of the RSD at each QC level, and the accuracy deviations were all within (100 ± 15)% of the actual values at each QC level. Therefore, this PC12 cells were pretreated with ECRP or PMFs for 24 h and then exposed to 100 µM H 2 O 2 for additional 4 h. PMF3, 5-hydroxy-6,7,8,3',4'-5 methoxy flavones; PMF4, 5,7,8,4'-4 methoxy flavones; PMF5, 5,6,7,3',4'-5 methoxy flavones; PMF6, 3, 5, 6, 7, 8, 3', 4 '-7 methoxy flavones. Data were represented as means ± SD (n = 5). ( * ) (P < 0.01), compared to that of the control group; ( ** ) (P < 0.01), compared to that of the injured group; ( ▲ ) (P < 0.05), compared to that of the injured group; ( ▲▲ ) (P > 0.05), compared to that of the injured group. method was of good precision and accuracy.
The extraction efficiencies measured for nobiletin and tangeretin in rat plasma were consistent, precise and reproducible.
The mean absolute extraction recoveries at each QC level (6.500, 250.0 and 2500 ng mL _ 1 ) were 95.35 ± 3.25, 90.59 ± 2.49 and 91.11 ± 6.33% for nobiletin (n = 5), and 96.22 ± 2.99, 94.12 ± 1.68 and 93.68 ± 2.35% for tangeretin (n = 5), respectively.
The low-temperature ( _ 20℃ and 4℃) and freeze-thaw stabilities of nobiletin and tangeretin (Table 3) showed that they
were reliably stable under the tested conditions.
Pharmacokinetic study The developed assay was sensitive adequately to measure nobiletin and tangeretin in rat plasma samples obtained following oral administration of ECRP. Since the two compounds were eliminated from the body almost linearly, the plasma concentration-time profiles (Fig. 4 and Fig. 5 ) were
analyzed by non-compartmental methods based on the statistical Table 4 demonstrated that both nobiletin and tangeretin were rapidly absorbed and then slowly decreased. The main pharmacokinetic parameters in our study were different from those reported in a previous study, probably owing to the difference between monomer and herbal medicine, as the latter has interactions between components.
Discussion
Oxidative damage in brain occurs in most neurodegenerative diseases, such as AD, Parkinson's disease, and Huntington's disease (Ankacrona et al., 1995) . PC12 cell line, which was initially derived from a rat adrenal medullary pheochromocytoma, (Greene and Tischler, 1976 (Sasaki et al., 2001; Chen et al., 2003; Heo et al., 2004) .
Although H 2 O 2 is not reactive per se, it forms highly reactive and deleterious hydroxyl radicals by the Fenton reaction in the presence of transition metal ions. Meanwhile, H 2 O 2 partially mediates the toxicity of Aβ, the major pathological hallmark for AD (Behl et al., 1994) . Therefore, H 2 O 2 has been adopted extensively to induce the apoptosis of various cells (Park et al., 2003; Ju et al., 2004) .
In this study, the protective effects of hesperidin and PMFs of ECRP on H 2 O 2 -induced cytotoxicity in PC12 cells were investigated by several biochemical assays. The data showed that most PMFs and ECRP were neuroprotective against H 2 O 2 -induced cytotoxicity in PC12 cells by diverse mechanisms and can at least be attributed to their antioxidant properties such as reduction of MDA levels and improvement of SOD and GSH-Px activities.
Unlike the widely studied nobiletin and tangeretin, the intracellular antioxidant activities of PMF3-6 have never been reported before.
However, it is worth noting that hesperidin, PMF3 and PMF4 exhibited weaker antioxidant effects in this study compared with other PMFs did. Because of the aglycone thereof, hesperidin's polar is so high that it can hardly penetrate the cell membrane. The relationship between structure and bioactivity of PMFs has been investigated (Kwaii et al., 2012; Vermeer et al., 2010) . Increasing methoxyl groups on the B-ring moiety lowers the activities of PMFs by A-ring methoxylation. When the number of A-ring methoxyl groups is 0 _ 3, attachment of more than two methoxyl groups on the B-ring moiety would completely diminish the activity. Although each of the PMFs with four methoxyl groups on To determine the contents of PMFs absorbed in blood, and to evaluate the bioavailability of PMFs in plant extract, the pharmacokinetics of nobiletin and tangeretin, which had maximum antioxidative components, were also studied. Compared with those of purified nobiletin and tangeretin in rat serum, the pharmacokinetic parameters in our study were different. The peakreaching time of tangeretin in serum after administration of purified tangeretin was close to that of ECRP administration, while the administration of purified nobiletin rendered the peak serum level much earlier than that of ECRP did. The results may be attributed to the difference between pure compound and plant extract, as the latter was subject to interaction between constituents. In addition, the method was the first LC-UV quantitative assay of nobiletin and tangeretin in rat plasma samples following oral administration of ECRP. Being specific, sensitive, accurate and reproducible, the method was successfully applied to the pharmacokinetic studies of PMFs in biological samples. Given the valuable findings herein, the tissue distributions of nobiletin and tangeretin, especially their presence in brain, should be further studied.
